SGLT2 Drugs Have Negative History with FDA

  5/21/2015 Quite surprising to me, I found that SGLT2 drugs have negative history with FDA. Not surprising, especially after finding the history, is the warning FDA released earlier this week. It appears that canagliflozin, sold as Invokana, may have created problems in the clinical trials that should have prevented its release. Just as other


TPP: The China Question

5/21/2015 As the Trans-Pacific Partnership (TPP) “fast track” debate continues its push through the congressional gauntlet, my fellow colleague Jay and I have analyzed hundreds of texts and perspectives surrounding the trade deal. We have covered labor, patent and trademarks, mass-torts, environmental concerns, and the highly controversial Investor State Dispute Resolution (ISDS) system, and little


Will Baseball’s Antitrust Exemption Survive the Supreme Court?

5/20/2015 Baseball is a game of eternal youth, and nothing may be more evident of that than listening to 95 year-old retired Supreme Court Justice, John Paul Stevens talk passionately about the future course of the sport. In a May 15th speech in front of the Sports Lawyers Association in Baltimore, Justice Stevens recalled his


Treatment Regimen for SGLT2-Related Ketoacidosis

5/19/2015 Yesterday we wrote about the warning issued by the FDA regarding SGLT2 type 2 diabetes medications. Today, I want to share the treatment regimen for SGLT2-related ketoacidosis. Always consult your physician before making changes in any medication protocol. If you find yourself experiencing any of the symptoms of ketoacidosis, get to the emergency room





The Legal Ramifications of Self-Driving Cars Part Two: Liability

5/18/2015 As mentioned in my last post, Google has just launched the first self-driving car onto public roadways near its California headquarters. This comes after the company recently admitted to the vehicles being involved in 11 minor accidents, with no injuries and little damage during 6 years of testing. These revelations confirm many people’s concerns



Fiat Chrysler Wants New Trial in Remi Walden Case

  5/16/2015 Fiat Chrysler wants new trial in the case of Remi Walden, a four-year-old boy who died in flames after his parents’ Jeep was rear-ended. I wrote last month about the $150M verdict the jury delivered in this case. The Walden’s 1999 Jeep Grand Cherokee, with an improperly placed gas tank, was little Remi’s